RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보 SCOPUS SCIE

      Genetic and Expression Analysis of the SIRT1 Gene in Gastric Cancers

      한글로보기

      https://www.riss.kr/link?id=A101559317

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: Silent mating-type information regulation 2 homologue 1 (SIRT1) is a nicotinamide adenine dinucleotide-dependent deacetylase. SIRT1 plays an important role in the regulation of cell death/survival and stress response in mammals. The aim of th...

      Purpose: Silent mating-type information regulation 2 homologue 1 (SIRT1) is a nicotinamide adenine dinucleotide-dependent deacetylase. SIRT1 plays an important role in the regulation of cell death/survival and stress response in mammals. The aim of this study was to investigate whether the SIRT1 gene is involved in the development or progression of gastric cancers. Materials and Methods: SIRT1 and p53 genes in 86 gastric cancers were examined for genetic alterations by PCR-single strand conformation polymorphism sequencing, as well as SIRT1 protein expression in 170 gastric cancers by immunohistochemistry. Results: In the genetic analysis, we found SIRT1 and p53 mutations in two and 12 cases, respectively. Two missense mutations, c.599 C>T (T200I) and c.1258 G>A (E420K), were detected in the SIRT1 gene coding region. The SIRT1 and p53 mutation were found in mutually exclusive gastric cancers. The immunohistochemistry revealed that SIRT1 overexpression was found in 95 (55.9%) of 170 gastric cancers. Altered SIRT1 expression was not statistically associated with clinicopathological parameters, including tumor differentiation, location, lymph node metastasis, or p53 expression. Two cases with an SIRT1 mutation showed increased SIRT1 expression. Conclusions: These results suggest that genetic alterations and overexpression of the SIRT1 gene may contribute to gastric cancer development.

      더보기

      참고문헌 (Reference)

      1 Nemoto S, "utrient availability regulates SIRT1 through a forkhead-dependent pathway" 306 : 2105-2108, 2004

      2 Uchino S, "p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer" 54 : 759-764, 1993

      3 Vaziri H, "hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase" 107 : 149-159, 2001

      4 Kononen J, "Tissue microarrays for high-throughput molecular profi ling of tumor specimens" 4 : 844-847, 1998

      5 Sheffield VC, "The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions" 16 : 325-332, 1993

      6 Firestein R, "The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth" 3 : 2020-, 2008

      7 Brunet A, "Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase" 303 : 2011-2015, 2004

      8 Ota H, "Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells" 25 : 176-185, 2006

      9 Bordone L, "SIRT1 transgenic mice show phenotypes resembling calorie restriction" 6 : 759-767, 2007

      10 Oberdoerffer P, "SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging" 135 : 907-918, 2008

      1 Nemoto S, "utrient availability regulates SIRT1 through a forkhead-dependent pathway" 306 : 2105-2108, 2004

      2 Uchino S, "p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer" 54 : 759-764, 1993

      3 Vaziri H, "hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase" 107 : 149-159, 2001

      4 Kononen J, "Tissue microarrays for high-throughput molecular profi ling of tumor specimens" 4 : 844-847, 1998

      5 Sheffield VC, "The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions" 16 : 325-332, 1993

      6 Firestein R, "The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth" 3 : 2020-, 2008

      7 Brunet A, "Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase" 303 : 2011-2015, 2004

      8 Ota H, "Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells" 25 : 176-185, 2006

      9 Bordone L, "SIRT1 transgenic mice show phenotypes resembling calorie restriction" 6 : 759-767, 2007

      10 Oberdoerffer P, "SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging" 135 : 907-918, 2008

      11 Jang KY, "SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma" 32 : 1523-1531, 2008

      12 Lee JH, "Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factorkappaB signaling pathway" 58 : 344-351, 2009

      13 Hasegawa K, "Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons" 28 : 8772-8784, 2008

      14 Wang RH, "Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice" 14 : 312-323, 2008

      15 Lim CS, "Human SIRT1: a potential biomarker for tumorigenesis?" 31 : 636-637, 2007

      16 Langley E, "Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence" 21 : 2383-2396, 2002

      17 Cha EJ, "Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma" 15 : 4453-4459, 2009

      18 Michishita E, "Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins" 16 : 4623-4635, 2005

      19 Fraga MF, "Epigenetics and aging: the targets and the marks" 23 : 413-418, 2007

      20 Murayama A, "Epigenetic control of rDNA loci in response to intracellular energy status" 133 : 627-639, 2008

      21 Fraga MF, "Cross-talk between aging and cancer: the epigenetic language" 1100 : 60-74, 2007

      22 Yuasa Y, "Control of gut differentiation and intestinal-type gastric carcinogenesis" 3 : 592-600, 2003

      23 Ford J, "Cancer-specifi c functions of SIRT1 enable human epithelial cancer cell growth and survival" 65 : 10457-10463, 2005

      24 Ford J, "Cancer-specifi c functions of SIRT1 enable human epithelial cancer cell growth and survival" 65 : 10457-10463, 2005

      25 Kim CJ, "Activation-induced cytidine deaminase expression in gastric cancer" 28 : 333-339, 2007

      26 Cohen HY, "Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis" 13 : 627-638, 2004

      27 Luo J, "Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo" 101 : 2259-2264, 2004

      28 Lee JY, "A simple, precise and economical microdissection technique for analysis of genomic DNA from archival tissue sections" 433 : 305-309, 1998

      29 Williams C, "A high frequency of sequence alterations is due to formalin fi xation of archival specimens" 155 : 1467-1471, 1999

      30 Hai-Rim Shin, "2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 Hospitals" 대한암학회 36 (36): 103-114, 2004

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2017-05-01 평가 SCIE 등재 (기타) KCI등재
      2015-07-31 학술지명변경 한글명 : 대한위암학회지 -> Journal of Gastric Cancer KCI등재
      2015-07-30 학술지명변경 외국어명 : Journal of Korean Gastric Cancer Association -> Journal of Gastric Cancer KCI등재
      2013-11-01 평가 SCOPUS 등재 (등재유지) KCI등재
      2013-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2012-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2011-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2009-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.46 0.24 0.35
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.31 0.37 0.461 0.05
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼